Back to CS Candriam S.C.A.
KPTI
Showing 0 of 21 quarters
Position history for CSCandriam S.C.A.'s holdings in Karyopharm Therapeutics Inc.
No. Candriam S.C.A. exited its KPTI (Karyopharm Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 530,694 shares worth $459,071. Candriam S.C.A. already held KPTI in its Q1 2019 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.